Buy & Sell Global X MSCI Argentina ETF (ARGT) – Global X MSCI Argentina ETF Price Today
Genflow Biosciences to present promising SIRT6 gene therapy results in aged dogs at October summit
Genflow Biosciences will present data from its Age Dogs clinical trial on centenarian SIRT6 gene therapy at the Animal Longevity Summit in Toronto this October. The trial shows promise in treating sarcopenia and longevity in aged dogs, with potential...
South Korea's KOSPI index swings wildly; Bitcoin drops to September 2024 lows amid market volatility.
South Korea's KOSPI index experienced extreme volatility this week, dropping 10% on Tuesday, then rebounding 3.3% and 5.4% on Wednesday and Thursday, before falling 5.8% on Friday. The U.S. Dollar Index reached a one-year high, while Bitcoin fell 5.3...
SELLAS Life Sciences nears key Phase 3 AML trial results with strong cash position and promising drug GPS.
SELLAS Life Sciences is advancing its acute myeloid leukemia (AML) treatment with its lead drug galinpepimut-S (GPS) approaching pivotal Phase 3 trial results in the REGAL study. The company also progresses another candidate, SLS009, targeting high-r...
Mitsubishi Electric posts strong revenue and profit growth despite restructuring costs.
Mitsubishi Electric Corporation reported solid revenue and operating profit growth driven by investments in electrification, semiconductors, datacenters, and defense. The life segment, including air conditioning and building systems, remains the larg...
Waton Financial launches MoTA Alpha, an AI-driven investment platform with a new agent marketplace and enhanced collaboration.
Waton Financial Limited has released MoTA Alpha, a major upgrade to its AI-powered investment platform that introduces an Agent Talents Market for third-party AI trading agents and improves multi-agent collaboration and user experience. This launch m...
Solvonis reports positive data advancing alcohol use disorder treatment using esketamine.
Solvonis Therapeutics announced positive preclinical pharmacokinetic data for its SVN-002 program, repurposing Johnson & Johnson's esketamine to treat moderate to severe alcohol use disorder. The data showed comparable drug exposure via sublingual an...
Solvonis reports positive data advancing alcohol use disorder drug to Phase 2b trial in the US.
Solvonis Therapeutics announced positive pharmacokinetic data for its SVN-002 program, repurposing J&J's esketamine for moderate to severe alcohol use disorder. The data show comparable drug exposure via sublingual and buccal delivery to the approved...
SpaceX IPO sparks investor interest in Rocket Lab as the next big public space launch company.
SpaceX's 2026 IPO on Nasdaq under the ticker SPCX has established a public market benchmark for the space launch economy, prompting investors to seek other investable companies in the sector. Rocket Lab Corporation (Nasdaq: RKLB) stands out with reco...
Gold prices face pressure but long-term bullish outlook remains intact despite recent selloff.
Gold prices have experienced a sharp selloff after reaching record highs, with major support levels breaking down. Short-term forecasts have been downgraded by analysts due to rising U.S. Treasury yields and a stronger dollar, which increase the cost...
Ryanair will let parents sit with kids free after UK regulator probes seating fees.
Ryanair has reversed its policy of charging parents a fee to sit next to their children after the UK's Competition and Markets Authority (CMA) launched an investigation into the practice. Previously, parents paid about $10.70 each way per adult to re...